Beta blockers in the management of chronic kidney disease
- 1 December 2006
- journal article
- review article
- Published by Elsevier in Kidney International
- Vol. 70 (11) , 1905-1913
- https://doi.org/10.1038/sj.ki.5001835
Abstract
No abstract availableKeywords
This publication has 109 references indexed in Scilit:
- Carvedilol increases two-year survivalin dialysis patients with dilated cardiomyopathyJournal of the American College of Cardiology, 2003
- Congestive heart failure in dialysis patients: Prevalence, incidence, prognosis and risk factorsKidney International, 1995
- Renal Effects of Antihypertensive Medications: An OverviewThe Journal of Clinical Pharmacology, 1993
- An Overview of the Pharmacodynamic Properties and Therapeutic Potential of Combined α- and β-Adrenoceptor AntagonistsDrugs, 1993
- Therapeutic Benefits and Safety of Carvedilol in the Treatment of Renal HypertensionDrugs, 1988
- Catecholamine Modulation of Rapid Potassium Shifts during ExerciseNew England Journal of Medicine, 1985
- Pharmacokinetic comparison of pindolol with other beta-adrenoceptor-blocking agentsAmerican Heart Journal, 1982
- Hemodynamics, biochemical and reflexive changes produced by atenolol in hypertension.Circulation, 1982
- The Pharmacokinetics of Metoprolol and its Metabolites in Dialysis PatientsClinical Pharmacokinetics, 1980
- Pharmacokinetic and Pharmacodynamic Properties of Metoprolol in Patients with Impaired Renal FunctionClinical Pharmacokinetics, 1980